Gastric cancer: Standards for the 21st century

Victor Archie, John Kauh, Dennie V. Jones, Victor Cruz, Martin S. Karpeh, Charles Thomas

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Although the incidence of gastric cancer has been decreasing in the United States, it remains a leading cause of cancer death in the world, only lung cancer causes more deaths worldwide. The combination of relatively low prevalence, lack of pathognomonic symptoms, and lack of defined risk factors are associated with a delay in diagnosis leading to a dismal prognosis. For localized disease, surgery remains a cornerstone of treatment but much controversy remains regarding optimal peri-operative therapy. For advanced disease, several new agents and new combination chemotherapies have offered encouraging results. This paper seeks to review the major topics surrounding gastric cancer and cover the results of recently reported and ongoing trials.

Original languageEnglish (US)
Pages (from-to)123-131
Number of pages9
JournalCritical Reviews in Oncology/Hematology
Volume57
Issue number2
DOIs
StatePublished - Feb 2006

Fingerprint

Stomach Neoplasms
Cause of Death
Combination Drug Therapy
Lung Neoplasms
Incidence
Therapeutics
Neoplasms

Keywords

  • Adenocarcinoma
  • Chemotherapy
  • Combined modality
  • Radiation therapy
  • Staging
  • Stomach cancer
  • Surgery

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Gastric cancer : Standards for the 21st century. / Archie, Victor; Kauh, John; Jones, Dennie V.; Cruz, Victor; Karpeh, Martin S.; Thomas, Charles.

In: Critical Reviews in Oncology/Hematology, Vol. 57, No. 2, 02.2006, p. 123-131.

Research output: Contribution to journalArticle

Archie, Victor ; Kauh, John ; Jones, Dennie V. ; Cruz, Victor ; Karpeh, Martin S. ; Thomas, Charles. / Gastric cancer : Standards for the 21st century. In: Critical Reviews in Oncology/Hematology. 2006 ; Vol. 57, No. 2. pp. 123-131.
@article{93b47e74f3ed447885581df255ca7cf8,
title = "Gastric cancer: Standards for the 21st century",
abstract = "Although the incidence of gastric cancer has been decreasing in the United States, it remains a leading cause of cancer death in the world, only lung cancer causes more deaths worldwide. The combination of relatively low prevalence, lack of pathognomonic symptoms, and lack of defined risk factors are associated with a delay in diagnosis leading to a dismal prognosis. For localized disease, surgery remains a cornerstone of treatment but much controversy remains regarding optimal peri-operative therapy. For advanced disease, several new agents and new combination chemotherapies have offered encouraging results. This paper seeks to review the major topics surrounding gastric cancer and cover the results of recently reported and ongoing trials.",
keywords = "Adenocarcinoma, Chemotherapy, Combined modality, Radiation therapy, Staging, Stomach cancer, Surgery",
author = "Victor Archie and John Kauh and Jones, {Dennie V.} and Victor Cruz and Karpeh, {Martin S.} and Charles Thomas",
year = "2006",
month = "2",
doi = "10.1016/j.critrevonc.2005.09.004",
language = "English (US)",
volume = "57",
pages = "123--131",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Gastric cancer

T2 - Standards for the 21st century

AU - Archie, Victor

AU - Kauh, John

AU - Jones, Dennie V.

AU - Cruz, Victor

AU - Karpeh, Martin S.

AU - Thomas, Charles

PY - 2006/2

Y1 - 2006/2

N2 - Although the incidence of gastric cancer has been decreasing in the United States, it remains a leading cause of cancer death in the world, only lung cancer causes more deaths worldwide. The combination of relatively low prevalence, lack of pathognomonic symptoms, and lack of defined risk factors are associated with a delay in diagnosis leading to a dismal prognosis. For localized disease, surgery remains a cornerstone of treatment but much controversy remains regarding optimal peri-operative therapy. For advanced disease, several new agents and new combination chemotherapies have offered encouraging results. This paper seeks to review the major topics surrounding gastric cancer and cover the results of recently reported and ongoing trials.

AB - Although the incidence of gastric cancer has been decreasing in the United States, it remains a leading cause of cancer death in the world, only lung cancer causes more deaths worldwide. The combination of relatively low prevalence, lack of pathognomonic symptoms, and lack of defined risk factors are associated with a delay in diagnosis leading to a dismal prognosis. For localized disease, surgery remains a cornerstone of treatment but much controversy remains regarding optimal peri-operative therapy. For advanced disease, several new agents and new combination chemotherapies have offered encouraging results. This paper seeks to review the major topics surrounding gastric cancer and cover the results of recently reported and ongoing trials.

KW - Adenocarcinoma

KW - Chemotherapy

KW - Combined modality

KW - Radiation therapy

KW - Staging

KW - Stomach cancer

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=31344475560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31344475560&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2005.09.004

DO - 10.1016/j.critrevonc.2005.09.004

M3 - Article

C2 - 16412659

AN - SCOPUS:31344475560

VL - 57

SP - 123

EP - 131

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 2

ER -